A Prospective, Single Center, Open Label, Randomized Controlled, Two Arm Study Evaluating Safety and Efficacy of the Permanent Polymer Zotarolimus Eluting Stent Resolute Integrity Compared to the Polymer Free Amphilimus Eluting Stent Cre8
Phase of Trial: Phase IV
Latest Information Update: 05 May 2017
At a glance
- Drugs Zotarolimus (Primary) ; Sirolimus
- Indications Acute coronary syndromes; Angina pectoris; Ischaemic heart disorders
- Focus Therapeutic Use
- 01 May 2017 Planned End Date changed from 1 Jan 2020 to 1 Sep 2020.
- 01 May 2017 Planned primary completion date changed from 1 Nov 2019 to 1 Sep 2018.
- 06 Jan 2015 New trial record